James T. Christie

James T. Christie is a Partner in the New York office of Labaton Keller Sucharow LLP.  James focuses on prosecuting complex securities fraud cases on behalf of institutional investors.  He is currently involved in litigating cases against major U.S. and non-U.S. corporations, such as Array, Estee Lauder, Fidelity National Information Services (FIS), Nikola, Opendoor, and StoneCo.  

James is a member of the Firm's Executive Committee and also serves as Assistant General Counsel and Co-Chair of the Technology Committee.

Seen as a rising star in securities litigation, James is recommended by The Legal 500 and has been named to Benchmark Litigation’s “40 & Under Hot List.”  He has been recognized as a “Rising Star of the Plaintiffs Bar” by The National Law Journal, a “Next Generation Lawyer” and “Leading Plaintiff Financial Lawyer” by Lawdragon, and a “Securities Rising Star” by Law360, which noted his leadership in several high-profile matters.  In addition, The Best Lawyers in America® listed him as one of the “Best Lawyers in America: Ones to Watch” in the Litigation: Securities category.

James was an integral part of the Firm’s team that helped recover $192.5 million for investors in a settlement for In re SCANA Corporation Securities Litigation.  James served in a critical role in recovering a $125 million settlement on behalf of investors in Boston Retirement System v. Alexion Pharmaceuticals, Inc.  James was a crucial part of a cross-border effort in In re Canntrust Holdings Securities Litigation that was able obtain a landmark CA$129.5 million settlement against a Canadian cannabis producer and its executive officers.  James was actively involved in litigating In re Okta, Inc. Securities Litigation, which resulted in a $60 million settlement.  James helped lead an effort in fast paced case litigated in the Eastern District of Virginia, In re Jeld-Wen Holding, Inc. Securities Litigation, where the Firm recovered $40 million for injured investors.  In addition, James was a key contributor to the Firm’s efforts in recovering $47 million for investors in a case against a vaccine manufacturer in Sinnathurai v. Novavax, Inc.  James also assisted in recovering $20 million on behalf of investors in Avila v. LifeLock, Inc., where he played a significant role in obtaining a key appellate victory in the Ninth Circuit Court of Appeals reversing the district court’s order dismissing the case with prejudice.  In addition, James assisted in the $14.75 million recovery secured for investors against PTC Therapeutics Inc., a pharmaceutical manufacturer of orphan drugs, in In re PTC Therapeutics, Inc. Securities Litigation.  

James previously served as a Judicial Intern in the U.S. District Court for the Eastern District of New York under the Honorable Sandra J. Feuerstein.

He is an active member of the American Bar Association, the Federal Bar Council, and the Georgia Association of Public Pension Trustees (GAPPT), where he serves on the Rules Committee.

James earned his Juris Doctor from St. John’s University School of Law, where he was the Senior Articles Editor of the St. John’s Law Review, and his Bachelor of Science, cum laude, from St. John’s University Tobin College of Business.